Enalapril, losartan and other medications that act on the renin-angiotensin-aldosterone system: Should their users be particularly concerned about COVID-19?

Enalapril, losartan and other medications that act on the renin-angiotensin-aldosterone system: Should their users be particularly concerned about COVID-19?

COVID-19

Enalapril, losartan and other medications that act on the renin-angiotensin-aldosterone system: Should their users be particularly concerned about COVID-19?   (We recommend reading this post on the basics of evidence-based medicine and the findings on COVID-19.)   Based on: Preliminary evidence (preclinical studies and initial human studies).   The development of a new drug, from…

SYSTEMATIC REVIEW –  PRELIMINARY REPORT – Lopinavir/ritonavir for the treatment of COVID-19

Preliminary reports

SYSTEMATIC REVIEW –  PRELIMINARY REPORT – Lopinavir/ritonavir for the treatment of COVID-19 Last update: 23 March 2020 This report does not constitute or replace a recommendation. It is an input for decision-makers to inform their processes with the best available evidence. A full systematic review will be submitted as soon as possible for publication in…